Industry experts with decades of experience in life sciences empowering pharmaceutical organizations with strategic insights, digital transformation, and operational excellence.
i2e leads digital transformation for the life sciences industry through best-in-class innovative technology solutions. Our market-leading execution capabilities and domain expertise help pharmaceutical companies, biotech, and healthcare organizations deliver innovations that create a healthier world.
We help R&D, clinical development, commercialization, pharmaceutical sciences, drug safety, regulatory functions accelerate time-to-value, prioritize industry-leading innovation, and establish portfolio leadership.
Named one of the fastest-growing private companies in the US in the 2023 Inc. 5000 list, i2e Consulting is life sciences' preferred partner for digital transformation. We are ISO9001 and ISM27001 certified, which is a recognition of our commitment towards continuous improvement of processes and data security.
CEO
With over 25 years of experience in the pharma IT industry, Sudhir has spent the last two decades transforming life sciences through data, analytics, and AI leadership. Sudhir is responsible for i2e’s strategy, growth, and innovation.
COO
Vishal leads market development, organizational transformation, and provides revenue and management leadership. Throughout his career, he has focused on business growth, expanding i2e’s global and regional footprint.
CDO
Sri leads i2e’s differentiating delivery architectures by providing technology vision and leadership across AI/ML, Big Data and Cloud. He leads the expansion of the service delivery portfolio by adding new service lines, capabilities, and partnerships.
Co-Founder
Prashant has been instrumental in building the business from the grounds up. In the early days, he managed business development, sales, and technology strategy. Now focused on an advisory capacity for achievement of goals and outcomes of the business.
VP - Portfolio Analytics
With 25 years of experience as an industry consultant, Carlos has led transformative initiatives in strategic portfolio management and digital innovation for top pharmaceutical organizations. A trailblazer in his field, he has designed and implemented strategic PPM roadmaps tailored to the needs of small, medium, and enterprise-level pharma companies.
Carlos played a pivotal role in conceptualizing and delivering enterprise-grade, real-time executive decision support tools. These tools empower data-driven decision-making in R&D asset investment analysis, scenario planning, and portfolio sustainability.
VP- Strategic PPM roadmap
With extensive experience in Portfolio & Project Management solutions, Brian has led impactful initiatives that align business processes with technical strategies. He has guided companies in designing and executing strategic PPM roadmaps to achieve operational excellence.
Brian’s diverse background in procurement, vendor management, and solution delivery equips him with a comprehensive perspective, enabling him to deliver customized solutions that address complex challenges and ensure sustainable outcomes.
VP- Data & Analytics
With 18 years of experience, Peter is a seasoned enterprise analytics professional who has played a pivotal role in advancing data-driven decision-making in the pharma organization. His expertise spans from R&D data & analytics, portfolio decision analytics, to business integration, where he has delivered impactful solutions to enhance strategic planning.
Peter’s background in analytics and integration equips him with the ability to bridge technical insights with business objectives, enabling organizations to unlock the full potential of their data.
Strategic Advisor
Dave brings nearly two decades of PPM expertise in the life sciences industry. At i2e, he advises on Go-To-Market strategies, PPM best practices, and emerging industry trends. With 17 years at Planisware, Dave held key leadership roles, including VP of Life Sciences, VP of Business Operations, Director of Consulting, and Solution Architect, driving innovation and operational excellence.
An authority in his field, Dave contributed to the 2023 book Project Management for Drug Developers authoring chapters on Project Management Information Systems.
Strategic Advisor
John brings over 30 years of experience delivering large-scale global transformational programs across life sciences, with a focus on driving innovation and operational excellence. His accomplishments include leading the digitalization of Pfizer’s Pre-Clinical R&D, Emerging Science & Innovation, and Worldwide R&D Operations, ensuring cutting-edge advancements in these critical areas.
His extensive expertise in digital transformation and strategic leadership positions him as a key contributor to advancing innovation in the pharmaceutical industry.
